allopurinol accord tablett
accord healthcare b.v. - allopurinool - tablett - 100mg 50tk; 100mg 30tk; 100mg 28tk; 100mg 100tk
allopurinol accord tablett
accord healthcare b.v. - allopurinool - tablett - 300mg 28tk; 300mg 30tk; 300mg 50tk; 300mg 60tk; 300mg 100tk; 300mg 25tk
tetmodis tablett
aop orphan pharmaceuticals gmbh - tetrabenasiin - tablett - 25mg 112tk
montelukast accord närimistablett
accord healthcare b.v. - montelukast - närimistablett - 5mg 98tk; 5mg 30tk; 5mg 90tk; 5mg 20tk; 5mg 14tk; 5mg 10tk; 5mg 100tk; 5mg 50tk; 5mg 7tk
montelukast fair-med 5mg närimistablett
fairmed healthcare gmbh - montelukast - närimistablett - 5mg 84tk; 5mg 28tk; 5mg 30tk; 5mg 140tk; 5mg 7tk; 5mg 50tk; 5mg 90tk; 5mg 14tk
montelukast fair-med 4mg närimistablett
fairmed healthcare gmbh - montelukast - närimistablett - 4mg 28tk; 4mg 50tk; 4mg 56tk; 4mg 200tk; 4mg 10tk; 4mg 20tk; 4mg 14tk; 4mg 7tk; 4mg 100tk
montelukast fair-med 10mg õhukese polümeerikattega tablett
fairmed healthcare gmbh - montelukast - õhukese polümeerikattega tablett - 10mg 100tk; 10mg 84tk; 10mg 56tk; 10mg 98tk; 10mg 200tk; 10mg 20tk; 10mg 140tk; 10mg 50tk; 10mg 90tk; 10mg 28tk; 10mg 30tk; 10mg 14tk; 10mg 7tk
montelukast accord närimistablett
accord healthcare b.v. - montelukast - närimistablett - 4mg 30tk; 4mg 100tk; 4mg 28tk; 4mg 20tk; 4mg 50tk; 4mg 56tk; 4mg 200tk; 4mg 14tk; 4mg 7tk; 4mg 10tk
trixeo aerosphere
astrazeneca ab - formoterol fumarate dihydrate, glycopyrronium bromide, budesonide - kopsuhaigus, krooniline obstruktiivne - ravimid hingamisteede obstruktiivsete haiguste, - trixeo aerosphere is indicated as a maintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (copd) who are not adequately treated by a combination of an inhaled corticosteroid and a long acting beta2 agonist or combination of a long-acting beta2 agonist and a long acting muscarinic antagonist.
riltrava aerosphere
astrazeneca ab - budesonide, formoterol fumarate dihydrate, glycopyrronium bromide - kopsuhaigus, krooniline obstruktiivne - ravimid hingamisteede obstruktiivsete haiguste, - riltrava aerosphere is indicated as a maintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (copd) who are not adequately treated by a combination of an inhaled corticosteroid and a long-acting beta2 agonist or combination of a long-acting beta2 agonist and a long-acting muscarinic antagonist (for effects on symptoms control and prevention of exacerbations see section 5.